Terazosin for benign prostatic hyperplasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Terazosin for benign prostatic hyperplasia

Published:2011-09-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wilt Timothy J¹,Howe R William²,Rutks Indy³,MacDonald Roderick¹

Affiliation:

1. VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

2. Lostwithiel Medical Practice; North Street Lostwithiel Cornwall UK PL22 0EF

3. VAMC; Department of Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

Publisher

Wiley

Subject

Pharmacology (medical)

Reference50 articles.

1. Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group

2. The International Terazosin Trial: A Multicentre Study of the Long-Term Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

3. Use of Terazosin in the Medical Treatment of Benign Prostatic Hyperplasia: Experience in Italy

4. PROSPECTIVE RANDOMIZED COMPARISON OF HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS alpha-BLOCKER TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

5. A multicenter, randomized, double-blind, placebocontrolled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence study of two formulations of terazosin hydrochloride capsule in healthy Chinese subjects under fasting and fed conditions;Int. Journal of Clinical Pharmacology and Therapeutics;2022-01-01

2. Systematic review and meta-analysis: α-adrenergic receptor blockers in chronic prostatitis;Annals of Palliative Medicine;2021-09

3. Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth;Naunyn-Schmiedeberg's Archives of Pharmacology;2013-11-10

4. Terazosin for benign prostatic hyperplasia;Cochrane Database of Systematic Reviews;2011-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3